Skip To The Main Content
Feb 28, 2024 Advancing the Study of Stroke in Women Conference, April 8-9, 2024

Registration is now open for the NINDS-sponsored 1.5 day conference entitled: Advancing the Study of Stroke in Women Through the Integration of Basic, Clinical and Socioeconomic Perspectives. WHEN: All day Monday, April 8, 2024 starting at 8:00 am (breakfast 7:30 am) and half day Tuesday, April 9th, 2024, starting at 7:45 am (breakfast 7:15) and ending at Noon WHERE: Sheraton Pentagon City, Arlington, VA (reduced rate of $199 + $28 taxes = $227 per night) CONFERENCE COST: $225 Use the links below for conference registration and hotel reservations. Full story

Feb 06, 2024 2024 Clinical Trials Methodology Course Call for Applications - Due March 4, 2024

We are pleased to announce the continuation of the NINDS Clinical Trials Methodology Course (CTMC). We are currently accepting applications for the 2024 cohort. The overarching goal of the CTMC is to help investigators develop scientifically rigorous, yet practical clinical trial protocols. Our focus is on investigators who have not previously designed their own prospective, interventional clinical trials. Applicants proposing large, multi-center trials will also be considered this year. The multi-center proposals should ideally be aligned with the focus areas of one of the established NINDS clinical research networks. Full story

Jul 08, 2022 2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage: A Guideline From the American Heart Association/American Stroke Association

Steven M. Greenberg, Wendy C. Ziai, Charlotte Cordonnier, Dar Dowlatshahi, Brandon Francis, Joshua N. Goldstein, J. Claude Hemphill III, Ronda Johnson, Kiffon M. Keigher, William J. Mack, J. Mocco, Eileena J. Newton, Ilana M. Ruff, Lauren H. Sansing, Sam Schulman, Magdy H. Selim, Kevin N. Sheth, Nikola Sprigg, Katharina S. Sunnerhagen, and on behalf of the American Heart Association/American Stroke Association, Published May 17, 2022 Full story

Jul 08, 2022 Use of Lipid-Lowering Drugs After Intracerebral Hemorrhage

Ashkan Shoamanesh, Magdy Selim, Published June 6, 2022 Full story

Jul 08, 2022 Focused Update on Vascular Risk and Secondary Prevention in Survivors of Intracerebral Hemorrhage

Kevin N. Sheth, MD, Magdy Selim, MD, PhD, Published June 27, 2022 Full story

Mar 18, 2020 NEW FDA Guidance on COVID-19

The Food and Drug Administration (FDA or Agency) plays a critical role in protecting the United States from threats including emerging infectious diseases, including the Coronavirus Disease 2019 (COVID-19) pandemic. F DA is committed to providing timely guidance to support continuity and response efforts to this pandemic. FDA is issuing this guidance to provide general considerations to assist sponsors in assuring the safety of trial participants, maintaining compliance with good clinical practice (GCP), and minimizing risks to trial integrity during the COVID-19 pandemic. Full story

Mar 17, 2020 StrokeNet COVID-19 Guidance

The primary concern for StrokeNet is the safety of our patients or potential patients for our ongoing trials. The second concern is the safety of our own investigators and study team members. Finally, we also want to maintain, as much as possible, the integrity of the trials to potentially benefit patients and so that the data can be used to answer the questions that the trials intended. This latter point is critical for subjects in the trial and those with the specific problem in the future. However, immediate safety issues take priority over any formal processes in ongoing trials. For example, while a current protocol may specify that a study visit needs to be in person, the FDA has guidance about the primary safety of study subjects: For more information click Full Story: Full story

Feb 27, 2020 Stroke v1.0 Common Data Elements (CDEs)

The National Institute of Neurological Disorders and Stroke (NINDS), and National Institutes of Health (NIH) recently assembled an external working group of international experts to update the Stroke v1.0 Common Data Elements (CDEs) based on user feedback and research advances. Full story